PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20159823-0	2010	Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate.	Abiraterone Acetate	126-145	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	110-115	
20159823-1	2010	PURPOSE: The principal objective of this trial was to evaluate the antitumor activity of abiraterone acetate, an oral, specific, irreversible inhibitor of CYP17 in docetaxel-treated patients with castration-resistant prostate cancer (CRPC).	Abiraterone Acetate	89-108	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	155-160